Clinical Trials on Tand, niet-vitaal

Total 415433 results

University Hospital, Limoges
Pierre Fabre Laboratories

Completed

Concomitant Radio-chemotherapy in the Elderly (RACCOSA)

Non Small Cell Lung Cancer

France
Bocconi University
AdvicePharma srl

Unknown

A Mobile Supportive Care App for Patients With Metastatic Lung Cancer (LuCApp)

Small Cell Lung Carcinoma | Nonsmall Cell Lung Cancer
French Innovative Leukemia Organisation

Terminated

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

B-cell Lymphoma

France
National Cancer Center, Korea

Withdrawn

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC)

Non Small Cell Lung Cancer

Korea, Republic of
Massachusetts General Hospital

Completed

AUY922 for Advanced ALK-positive NSCLC

Non Small Cell Lung Cancer

United States
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (CSET 1437)

Non Small Cell Lung Cancer

France
Centre Oscar Lambret

Completed

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (MetLung)

Non Small Cell Lung Cancer

France
Massachusetts General Hospital
American Society of Clinical Oncology

Completed

Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States
Xinqiao Hospital of Chongqing

Unknown

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Massachusetts General Hospital
Boehringer Ingelheim; University of Texas

Completed

Understanding Mechanisms of Acquired Resistance to BIBW2992

Non-small Cell Lung Cancer | EGFR Mutations

United States
University of Louisville
James Graham Brown Cancer Center

Terminated

Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer (BIT-2)

Non-small Cell Lung Cancer

United States
Sun Yat-sen University
Shanghai Chest Hospital; Shenzhen People's Hospital; Shanghai Pulmonary Hospital... and other collaborators

Unknown

A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
University Health Network, Toronto
Hoffmann-La Roche

Completed

Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) (SELECT)

Non Small Cell Lung Cancer

Canada
AEterna Zentaris

Completed

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

United States
Tang-Du Hospital
LinkDoc Technology (Beijing) Co. Ltd.

Unknown

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

Non Small Cell Lung Cancer

China
University of Louisville
James Graham Brown Cancer Center

Terminated

The Effect of Berries on Lung Cancer Tumors

Non Small Cell Lung Cancer

United States
Southwest Hospital, China

Unknown

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Cellular Biomedicine Group Ltd.
Tianjin Medical University Cancer Institute and Hospital

Unknown

A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma

China
Asociación para la Investigación del Cáncer de...
Pivotal S.L.

Terminated

Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer (IMPULSO)

Non-small Cell Lung Cancer

Spain
Pharmacyclics LLC.
Janssen Research & Development, LLC

Completed

Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States, Australia, Belgium, Canada, China, Czechia, Ireland, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
Institute of Liver and Biliary Sciences, India

Withdrawn

To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.

Cirrhosis

India
Abbott
Almedis

Completed

IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice (PRESTO)

Headache Disorders, Primary | Tension-Type Headache | Migraine Without Aura | Migraine With Aura

Kazakhstan, Ukraine
West Virginia University
Celgene Corporation

Withdrawn

Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.

Non-small Cell Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer (TARGET)

Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Hoffmann-La Roche
Genentech, Inc.

Terminated

A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

B-cell Lymphoma

Italy, China, United States, New Zealand, Canada, Australia, Austria, France, Spain, United Kingdom, Brazil, Colombia, Russian Federation, Thailand, Germany, Panama, Peru, Korea, Republic of, Hong Kong, Sweden, Argentina, Ecuador, P... and more
National Cancer Institute (NCI)

Completed

T-Cell Project: Epidemiologic Component

Peripheral T-Cell Lymphoma

United States
GlaxoSmithKline

Completed

A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

Leukaemia, Lymphocytic, Chronic

Korea, Republic of, Japan
Chinese University of Hong Kong

Completed

PET-CT and Circulating Tumor Cells in Colorectal Cancer

Colorectal Cancer | Metastasis

Hong Kong
Massachusetts General Hospital
Bristol-Myers Squibb; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical...

Terminated

Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

B-cell Lymphoma
Massachusetts General Hospital
Dana-Farber Cancer Institute; Genentech, Inc.; Celgene Corporation

Completed

Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Vanderbilt University Medical Center
National Institutes of Health (NIH); National Center for Complementary and...

Completed

Study of Effects of L-Arginine in Colitis and Colon Cancer

Ulcerative Colitis | Colon Cancer

United States
VA Office of Research and Development
Oregon Health and Science University

Completed

Developing and Testing a Comprehensive MS Spasticity Management Program

Multiple Sclerosis | Spasticity

United States
Biogen
Elan Pharmaceuticals

Completed

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients (TIMER)

Relapsing Remitting Multiple Sclerosis (RRMS)

Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
Centaurus Biopharma Co., Ltd.

Unknown

Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
University of Ulm

Completed

Concentration of Ertapenem in Colorectal Tissue

Rectal Neoplasms | Colonic Neoplasms | Diverticulosis, Colonic

Germany
John Byrd

Completed

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Jinming Yu
Roche Pharma AG

Unknown

Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 (RECEL)

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR

Non-small Cell Lung Cancer

China
Massachusetts General Hospital

Completed

Effects of Pennsaid on Clinical Neuropathic Pain

Neuralgia | Reflex Sympathetic Dystrophy | Postherpetic Neuralgia | Complex Regional Pain Syndrome (CRPS)

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Completed

Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis

Immunosuppression | Anterior Uveitis | Arthritis, Juvenile Idiopathic | Iritis

United States
Novartis Pharmaceuticals

Completed

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukemia (CLL) | Leukaemia, Lymphocytic, Chronic

United States, Belgium, Italy, Greece, Russian Federation, Spain, Poland, Czech Republic
Biogen

Completed

Safety Study of BIIB033 in Subjects With Multiple Sclerosis

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis

United States
Seattle Children's Hospital
Cures Within Reach

Unknown

Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors (SEED)

Recurrent Childhood Brain Tumor

United States
Angiodynamics, Inc.

Terminated

Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE) (PROVIDE)

Chronic Kidney Disease | Acute Kidney Injury | Acute Renal Failure | Renal Failure Chronic Contrast Induced

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group

Completed

Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer

Non-small-cell Lung Cancer

Greece
German CLL Study Group

Terminated

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocytic Leukemia

Germany
Peking University People's Hospital

Unknown

Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC

Non-small Cell Lung Cancer

China
Providence Health & Services
National Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni Foundation

Completed

Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer (DRibble)

Non Small Cell Lung Cancer

United States

Clinical Trials on Tand, niet-vitaal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations